On-Demand Webinars
-
Your Journey To GMP With Emphasis On Linker Payload Development
10/22/2025
Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.
-
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
10/22/2025
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
-
Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches
10/22/2025
Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.
-
Game-Changing CLD Platforms: Strategies, Technologies, Workflows
10/21/2025
Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.
-
In-Line PAT Solutions For cGMP Environments
10/21/2025
Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.
-
Development Of An Off-The-Shelf γδ T-Cell Platform
10/20/2025
Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.
-
AI In Action: Driving Operational Excellence In Life Sciences
10/20/2025
Discover how combining domain expertise with advanced AI and data engineering automates compliance, accelerates readiness, and provides real-time insights for confident decision-making.
-
Maximizing Yield And Purity With Praesto™ CH1 Resin
10/17/2025
Explore a new resin designed to simplify antibody purification, improve yield, and enhance contaminant removal during the capture step—ideal for complex therapeutics and GMP workflows.
-
Selective Degradation Of Cancer Target WDR5
10/17/2025
Explore how to enable precise biophysical characterization of PROTACs targeting WDR5 to help overcome challenges with undruggable cancer proteins and complex interactions.
-
How To Keep Your Degrader Pipeline Moving Forward
10/17/2025
Discover a new biophysical method that simplifies PROTAC characterization, improves assay development, and delivers high-quality affinity data even for complex interactions.